#genetic testing

Individuals would better understand their personal cancer risks for multiple cancers, make informed decisions

A small group of adults in remission had persisting mutations that predicted their risk of death from having the cancer return.

Immunotherapy and … nothing else? Studies test a potential paradigm shift in treatment for some people with early stage cancers.

Some people have inherited genetic syndromes that increase their risk for colon cancer.

Drugs developed to target particular genetic changes may not be right for every person whose cancer shows those alterations or mutations.

Study finds that risk of adverse side effects from cancer immunotherapy is higher in patients with certain inherited genetic variations.

Rezlidhia (olutasidenib) is approved as a targeted treatment option for adults whose acute myeloid leukemia carries the IDH1 mutation.

Music teacher Winona Williams lives a life not dominated by her ovarian cancer diagnosis—and she hopes her treatment will help others.

The clinical significance of many of the inherited mutations that can now be identified remains unclear.

The NCCN updated its guidelines for genetic testing for colorectal cancer patients; increased testing can reduce health disparities.

Embryos in the womb can get gene mutations that lead to cancer in adulthood.

Patients with recurrent lesions genetically distinct from the primary tumor may require different treatment.

Researchers identified 128 PSA-associated genetic variants, including 82 new ones, which they used to build a risk score.

Study confirms that Black men are at higher risk for prostate cancer disease progression and death.

University of California San Francisco researchers uncover common immune microenvironments across different types of cancer.

P-NET is a “biologically informed deep learning model” capable of guessing a prostate cancer patient’s disease state.